ZS Pharma

Research
Biotech

Allergy, inflammation player Allakos reels in $100M series B

Allakos has picked up a hefty $100 million to propel its antibody treatments through the clinic.
Amirah Al Idrus Dec 13, 2017 5:09pm
AstraZeneca

AstraZeneca’s $2.7B ZS-9 rejected again by FDA

Mar 17, 2017 7:06am
AZN

Relypsa sets up hyperkalemia showdown with AstraZeneca

Apr 25, 2016 8:38am